Shire Tells Fed Circuit It Erred In Generic Vyvanse Suit
Shire LLC on Monday asked the Federal Circuit to rehear en banc its decision that a pharmaceutical ingredient supplier can't be held liable in a patent infringement case because it didn't...To view the full article, register now.
Already a subscriber? Click here to view full article